Related references
Note: Only part of the references are listed.Meta-analysis of data from animal studies: A practical guide
H. M. Vesterinen et al.
JOURNAL OF NEUROSCIENCE METHODS (2014)
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride
Tarunya Arun et al.
BRAIN (2013)
Computational Drug Repositioning: From Data to Therapeutics
M. R. Hurle et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Predictive methods in drug repurposing: gold mine or just a bigger haystack?
David Cavalla
DRUG DISCOVERY TODAY (2013)
Contribution of Genome-Wide Association Studies to Scientific Research: A Pragmatic Approach to Evaluate Their Impact
Vito A. G. Ricigliano et al.
PLOS ONE (2013)
Plug the real brain drain
Martin Schwab et al.
NATURE (2012)
Drug repurposing programmes get lift off
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Scientific Value of Systematic Reviews: Survey of Editors of Core Clinical Journals
Joerg J. Meerpohl et al.
PLOS ONE (2012)
Amyotrophic Lateral Sclerosis: Drug Therapy from the Bench to the Bedside
Summer Bell Gibson et al.
SEMINARS IN NEUROLOGY (2012)
Inflammation, demyelination, and degeneration - Recent insights from MS pathology
Christine Stadelmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease
Hans Lassmann
JOURNAL OF NEURAL TRANSMISSION (2011)
Critical appraisal of animal models of multiple sclerosis
David Baker et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Could pharma open its drug freezers?
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2011)
Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes
Igor Allaman et al.
PSYCHOPHARMACOLOGY (2011)
Improving the translational hit of experimental treatments in multiple sclerosis
Hanna M. Vesterinen et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Ibudilast in relapsing-remitting multiple sclerosis A neuroprotectant?
F. Barkhof et al.
NEUROLOGY (2010)
Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy
Emily S. Sena et al.
PLOS BIOLOGY (2010)
Can Animal Models of Disease Reliably Inform Human Studies?
H. Bart van der Worp et al.
PLOS MEDICINE (2010)
Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease
P. Rolan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Predicting new molecular targets for known drugs
Michael J. Keiser et al.
NATURE (2009)
Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study
J. P. Mostert et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Drug target identification using side-effect similarity
Monica Campillos et al.
SCIENCE (2008)
Oxcarbazepine for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study
C. Solaro et al.
NEUROLOGICAL SCIENCES (2007)
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
Ralf Gold et al.
BRAIN (2006)
Fluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis
JP Mostert et al.
NEUROSCIENCE LETTERS (2006)
Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases
Suhayl Dhib-Jalbut et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design
Raju Kapoor
CURRENT OPINION IN NEUROLOGY (2006)
Secondary progressive multiple sclerosis: current knowledge and future challenges
M Rovaris et al.
LANCET NEUROLOGY (2006)
Target-based drug discovery: is something wrong?
F Sams-Dodd
DRUG DISCOVERY TODAY (2005)
A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis
JE Walker et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Pooling of animal experimental data reveals influence of study design and publication bias
MR Macleod et al.
STROKE (2004)
Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration
EKC Kong et al.
NEUROCHEMICAL RESEARCH (2002)
Share Paper
